Research Methods & Evidence
An evidence-first index for analytical documentation, assay concepts, and research-compound questions.
HPLC vs. LC-MS: What Each Method Can and Cannot Establish for Research-Peptide Analysis
HPLC and LC-MS/MS provide different kinds of analytical evidence. An HPLC chromatogram can separate components under a defined method and can support a relative peak-area or impurity-profile interpretation when the procedure is appropriate and validated. LC-MS/MS can add mass and product-ion information relevant to molecular characterization. Neither a dominant HPLC peak nor a single mass result, by itself, establishes every structural feature, impurity, quantitative-purity value, or biological property of a research peptide.
Read guide →RESEARCH GUIDESterility, Bioburden, and Microbial-Limit Terms in Research Quality Documentation
Sterility-test, bioburden or microbial-enumeration, bacterial-endotoxin, identity, and purity terms refer to different measurements or documentation contexts. A result can support only the limited conclusion tied to its stated method, sample, conditions, and acceptance framework. No individual result—or an unverified certificate of analysis—guarantees every quality attribute, absence of all contaminants, safety, or suitability for any human or clinical purpose.
Read guide →RESEARCH GUIDEHow to Interpret Scientific Evidence in Biochemical Research: Methods, Mechanisms, and Claims
Scientific evidence is not a single ladder that proves every claim at the top. Analytical validation, mechanistic studies, preclinical models, evidence syntheses, and controlled human studies answer different questions and have different limits. A reliable interpretation asks whether the measurement was valid, whether the model matches the claim, how consistent and direct the evidence is, and whether the stated conclusion is narrower than the evidence.
Read guide →RESEARCH GUIDEPeptide Storage and Freeze–Thaw Degradation: What Research Records Can Establish
Research literature and stability records can establish how a defined sample performed under defined experimental conditions when an appropriate analytical method was used. They do not support a universal storage window, temperature, or freeze–thaw limit for every peptide. Sequence, formulation, physical state, container, exposure history, and the measurement method can all affect the stability question being asked.
Read guide →RESEARCH GUIDEAnalytical Method Validation for Peptide Quantification: Specificity, Linearity, Recovery, and Matrix Effects
Specificity, linearity, accuracy, precision, recovery, and matrix effects are distinct analytical performance characteristics. A method can appear linear over a stated range while still having an interference, recovery, or matrix-response problem. Validation asks whether the procedure is fit for its stated purpose; no single statistic, including a correlation coefficient, substitutes for the full evidence needed for that purpose.
Read guide →RESEARCH GUIDEEstablishing Dose-Response Relationships Through Pharmacodynamic Assays in Research
Dose-response relationships in research are estimated from predefined pharmacodynamic endpoints across test concentrations. This guide explains the study-design logic without translating it into personal dosing.
Read guide →RESEARCH GUIDEBPC-157 in Gastric Juice: Reported Stability and Open Mechanistic Questions
Review literature reports describing BPC-157 in gastric or acidic conditions and the mechanistic questions the reviewed evidence does not resolve. The guide distinguishes reported stability from an experimentally demonstrated structural explanation.
Read guide →RESEARCH GUIDEBacteriostatic Water Composition: Preservative Efficacy of 0.9% Benzyl Alcohol in Reconstitution
Bacteriostatic Water for Injection is labeled as sterile water containing 0.9% benzyl alcohol as a preservative. This guide explains what labeling and aseptic-processing records document, and what they do not establish about a finished research preparation.
Read guide →RESEARCH GUIDECJC-1295 Drug Affinity Complex: Pharmacokinetic Evidence Context
The cited CJC-1295 records describe albumin-binding Drug Affinity Complex design and study-specific duration findings. This guide explains what those studies establish and what direct-comparator questions remain unanswered.
Read guide →RESEARCH GUIDEMitochondrial-Derived Peptide MOTS-c and Skeletal Muscle Metabolic Regulation
Preclinical and cell studies describe MOTS-c as a mitochondrial-derived peptide associated with metabolic regulation in skeletal-muscle research models. This guide explains those model-bound findings and their limits.
Read guide →RESEARCH GUIDEMetabolic Reprogramming and ERR Agonist Signaling of SLU-PP-332
Preclinical studies of SLU-PP-332 describe estrogen-related receptor agonism and metabolic-program changes in model systems. This guide separates those model-bound findings from conclusions not established by the cited record.
Read guide →RESEARCH GUIDEConfirming Molecular Weight and Structure via Tandem Mass Spectrometry (LC-MS/MS)
Tandem mass spectrometry strengthens peptide identification by evaluating precursor and product-ion evidence within a validated analytical method. This guide explains what that evidence can and cannot establish.
Read guide →RESEARCH GUIDETB-500 and Thymosin Beta-4: Analytical Context for the LKKTETQ Region
The cited analytical record describes TB-500 as an N-acetylated LKKTETQ sequence related to an active thymosin beta-4 region. This guide distinguishes that analytical context from full-length thymosin beta-4 biology.
Read guide →RESEARCH GUIDEQuantifying Peptide-Receptor Affinity: Competitive and Non-Competitive Binding Assays
Competitive and non-competitive receptor-binding assays quantify different aspects of ligand interaction in defined systems. This guide explains the measurement logic and the limits of affinity claims.
Read guide →RESEARCH GUIDEQuantifying Peptide Concentrations in Biological Fluids: Competitive vs. Sandwich ELISA Protocols
Competitive and sandwich ELISAs use different antibody and analyte arrangements for bioanalytical measurement. This guide compares their research-method roles and validation limits.
Read guide →RESEARCH GUIDEHow do independent third-party laboratories validate peptide analytical data?
Independent laboratory validation relies on documented quality systems and method-specific analytical evidence. This guide explains how ISO/IEC 17025 and FDA validation principles inform document review.
Read guide →RESEARCH GUIDEGABAergic Modulation and Anxiolytic Pathways of the Tuftsin Derivative Selank
The cited preclinical Selank literature describes GABAergic and neuropharmacological observations in defined research models. This guide separates those findings from unsupported human extrapolation.
Read guide →RESEARCH GUIDEPeptide Analog vs. Native Peptide: Structural Modifications and Stability
This guide addresses how do synthetic peptide analogs differ structurally and functionally from native endogenous peptides? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →RESEARCH GUIDEComprehensive Guide to Reviewing Certificates of Analysis (COA) for Research Compounds
This guide addresses what key analytical metrics must be verified when reviewing a certificate of analysis (coa) for research compounds? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →RESEARCH GUIDEEnzymatic Inhibition of NNMT by 5-Amino-1MQ in Adipose Tissue Research
This guide addresses how does 5-amino-1mq function as a selective inhibitor of nicotinamide n-methyltransferase (nnmt)? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →RESEARCH GUIDEMeasuring Cellular Viability and Cytotoxicity: MTT and LDH Assay Methodologies
This guide addresses how do mtt and ldh assays measure cellular viability and cytotoxicity in preclinical screening? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →RESEARCH GUIDEInterpreting HPLC Purity Chromatograms for Research Compound Verification
This guide addresses how do hplc purity chromatograms validate compound identity and purity in research catalogs? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →RESEARCH GUIDENAD+ Coenzyme Redox Cycling and Sirtuin Pathway Activation Mechanisms
This guide addresses how does nad+ participate in cellular oxidation-reduction cycling and sirtuin-mediated enzyme activation? using the cited experimental, analytical, or regulatory record. It is written for laboratory research and document interpretation only; it does not provide personal-use, dosing, administration, or treatment guidance.
Read guide →